Q: Pls comment on CFO departure.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: would appreciate an update on CEW...
the lifeco's are on the rise but the banks are in the doldrums!
what is your outlook for the banks for the short term?
do you think it would be a good time to add to some more CEW to
portfolio (currently at about 2 1/2%)
many thanks - ed
the lifeco's are on the rise but the banks are in the doldrums!
what is your outlook for the banks for the short term?
do you think it would be a good time to add to some more CEW to
portfolio (currently at about 2 1/2%)
many thanks - ed
Q: Hi Team,
I know you mostly comment on stocks, and I have read your previous commentary on MRC.
I have a hole to plug in my five-year bond ladder which serves as the low risk side of my portfolio. I was thinking of buying an MRC bond maturing 12/10/18, CUSIP 617577AA9, as a small fraction of my bond holdings. Do you think this is a reasonably "safe" investment even though it carry's a BBB low rating? I plan to hold to maturity.
Thank you. Michael
I know you mostly comment on stocks, and I have read your previous commentary on MRC.
I have a hole to plug in my five-year bond ladder which serves as the low risk side of my portfolio. I was thinking of buying an MRC bond maturing 12/10/18, CUSIP 617577AA9, as a small fraction of my bond holdings. Do you think this is a reasonably "safe" investment even though it carry's a BBB low rating? I plan to hold to maturity.
Thank you. Michael
Q: Small cap --y-4% opinion on divided safety, outlook for stock over 2-+ years
Can they grow the business & how ?
Thanks ---Don
Can they grow the business & how ?
Thanks ---Don
Q: Hello Peter and company. I am interested in your views on Sylogist Ltd. This company looks to be very similar to a micro CSU. How do you rate the balance sheet and future growth. Do you see the possibility of others in the space seeing this company as a interesting small roll up.
I was also wondering if I might pose this question to you. Given the current environment with Obama Care being extended,Canadian companies looking to acquire and interest rates very low around the world. If you where going to invest in 3 companies with high growth and good balance sheets what would they be. Thank you as always and keep up the great work. Jason
I was also wondering if I might pose this question to you. Given the current environment with Obama Care being extended,Canadian companies looking to acquire and interest rates very low around the world. If you where going to invest in 3 companies with high growth and good balance sheets what would they be. Thank you as always and keep up the great work. Jason
Q: Hello, my question is about the "Macroeconomic report card". What is the definition of "TSX Comp.Yield"? On the macroeconomic report card of June 15th, you report a yield of 3.30%, is this the dividend yield only? I am asking because it seems to me a little bit high. (same question apply to the S&P500 yield). Thanks, Gervais
Q: Afternoon folks, this stock was in an article in the FP today identified as a preferred financial stock by Lightwater Partners. Your thoughts would be appreciated.
Q: Hi Peter and Team,
Any thoughts on CriticalControl Solutions? CCZ
Any thoughts on CriticalControl Solutions? CCZ
Q: Hello Peter and Company. Could I have your thoughts on Flour Corp. I have noticed a slower but continued uptake for it's services as noted in recent awarded contracts. Do you believe this is a attractive price for a company that is still growing? I am also interested in any margin or depletion of cash from the balance sheet you may see.
Thank you Jason
Thank you Jason
Q: I recently browsed through the 2014 annual report of western forest and was surprised to discover that the native tribes may have a claim on their lands. Do I need to be concerned?
Q: Is this a buying opportunity in Enercare, the stock erased all is gain of 2015 and yield around 6.3%. Seem a bit overdone here, whats your thought.
thanks.
thanks.
Q: Is there an obvious reason to the drop off in price of PLI in the last month. I've read nothing negative.
Thanks
Jim
Thanks
Jim
Q: Are there any companies in your Income or Balanced portfolios you would be comfortable buying for a three year hold? Or is that too short of a timeframe?
Q: RBC came out with a research note on CSU this morning and a $475 target price (well below market price).
Do you agree, and can you comment on their observations I'm quoting below plse:
"In light of the divergence between Constellation’s current pace of acquisitions and valuation, RBC CM wanted to outline the conditions necessary and scenario for re-acceleration in acquisitions. The analyst believes a reduction in Constellation’s hurdle rate is needed to counter the elevated pricing environment and drive material re-acceleration in acquisitions. In the meantime, RBC CM sees acquisitions below FCF and Constellation deleveraging. RBC CM believes Constellation’s long-term fundamentals remain attractive. However, valuation multiples near the high end of Constellation’s historical range have diverged from its slower pace of M&A. RBC CM’s C$475 target equates to 16x CY16E EV/EBITDA on $519MM CY16E adj. EBITDA."
Thanks
Do you agree, and can you comment on their observations I'm quoting below plse:
"In light of the divergence between Constellation’s current pace of acquisitions and valuation, RBC CM wanted to outline the conditions necessary and scenario for re-acceleration in acquisitions. The analyst believes a reduction in Constellation’s hurdle rate is needed to counter the elevated pricing environment and drive material re-acceleration in acquisitions. In the meantime, RBC CM sees acquisitions below FCF and Constellation deleveraging. RBC CM believes Constellation’s long-term fundamentals remain attractive. However, valuation multiples near the high end of Constellation’s historical range have diverged from its slower pace of M&A. RBC CM’s C$475 target equates to 16x CY16E EV/EBITDA on $519MM CY16E adj. EBITDA."
Thanks
Q: Hi Peter and team, Any reason (other than the expected interest rate hike) for the under performance of FCR? If you still like FCR, what % of portfolio would you recommend?
Thank you very much for all you do to help us.
Silvia
Thank you very much for all you do to help us.
Silvia
Q: If you had to pick one stock that could possibly replicate CSU's 1,000+% return over the next 5+ yrs, what would that stock be?
Q: Wouuld this be a profitable stock to have in a portfolio.Eddie.
Q: Good morning team 5i. I am in the middle of rebalancing my very well diversified 4 PFs, that is doing well all in all with most of your stock suggestions in your PFs (THANK YOU). I treat them as one PF. Around Apr 23/15, you mentioned that an investor should have no more than 15% to 20% in Small Caps. Around June 16/15 you mentioned Cap Sizes are as follows; SMALL - 75 million to 500 million, MID - 500 mill to 1 Billion, and LARGE -1 Billion and above. Canadian Business Magazine 2015 Special Edition on Pg 127, mentions SMALL 1 Billion or less, MID - 1 to 5 Billion, and LARGE - 5 Billion and up.
Would you please clarify this for me?!! If I follow Can Bus. Mag I am too heavily weighted in small caps!
Also would IWO ETF be considered SMALL or do ETFs fit the consideration of Cap size?
Would you please clarify this for me?!! If I follow Can Bus. Mag I am too heavily weighted in small caps!
Also would IWO ETF be considered SMALL or do ETFs fit the consideration of Cap size?
Q: Please comment on Healthcare Special Opportunities Fund spearheaded by Michael Dalsin of Patient Home Monitoring.
Thank You
Thank You
Q: Am I to understand that ENB drop down asset into ENF would be advantages to ENF ? Will the deal put ENF into better growth position, perhaps be able to increase dividends in the near future?
Many hanks, Joe. P.
Many hanks, Joe. P.